Cargando…

CRISPR-Cas3 induces broad and unidirectional genome editing in human cells

Although single-component Class 2 CRISPR systems, such as type II Cas9 or type V Cas12a (Cpf1), are widely used for genome editing in eukaryotic cells, the application of multi-component Class 1 CRISPR has been less developed. Here we demonstrate that type I-E CRISPR mediates distinct DNA cleavage a...

Descripción completa

Detalles Bibliográficos
Autores principales: Morisaka, Hiroyuki, Yoshimi, Kazuto, Okuzaki, Yuya, Gee, Peter, Kunihiro, Yayoi, Sonpho, Ekasit, Xu, Huaigeng, Sasakawa, Noriko, Naito, Yuki, Nakada, Shinichiro, Yamamoto, Takashi, Sano, Shigetoshi, Hotta, Akitsu, Takeda, Junji, Mashimo, Tomoji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6897959/
https://www.ncbi.nlm.nih.gov/pubmed/31811138
http://dx.doi.org/10.1038/s41467-019-13226-x
_version_ 1783476987497545728
author Morisaka, Hiroyuki
Yoshimi, Kazuto
Okuzaki, Yuya
Gee, Peter
Kunihiro, Yayoi
Sonpho, Ekasit
Xu, Huaigeng
Sasakawa, Noriko
Naito, Yuki
Nakada, Shinichiro
Yamamoto, Takashi
Sano, Shigetoshi
Hotta, Akitsu
Takeda, Junji
Mashimo, Tomoji
author_facet Morisaka, Hiroyuki
Yoshimi, Kazuto
Okuzaki, Yuya
Gee, Peter
Kunihiro, Yayoi
Sonpho, Ekasit
Xu, Huaigeng
Sasakawa, Noriko
Naito, Yuki
Nakada, Shinichiro
Yamamoto, Takashi
Sano, Shigetoshi
Hotta, Akitsu
Takeda, Junji
Mashimo, Tomoji
author_sort Morisaka, Hiroyuki
collection PubMed
description Although single-component Class 2 CRISPR systems, such as type II Cas9 or type V Cas12a (Cpf1), are widely used for genome editing in eukaryotic cells, the application of multi-component Class 1 CRISPR has been less developed. Here we demonstrate that type I-E CRISPR mediates distinct DNA cleavage activity in human cells. Notably, Cas3, which possesses helicase and nuclease activity, predominantly triggered several thousand base pair deletions upstream of the 5′-ARG protospacer adjacent motif (PAM), without prominent off-target activity. This Cas3-mediated directional and broad DNA degradation can be used to introduce functional gene knockouts and knock-ins. As an example of potential therapeutic applications, we show Cas3-mediated exon-skipping of the Duchenne muscular dystrophy (DMD) gene in patient-induced pluripotent stem cells (iPSCs). These findings broaden our understanding of the Class 1 CRISPR system, which may serve as a unique genome editing tool in eukaryotic cells distinct from the Class 2 CRISPR system.
format Online
Article
Text
id pubmed-6897959
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-68979592019-12-09 CRISPR-Cas3 induces broad and unidirectional genome editing in human cells Morisaka, Hiroyuki Yoshimi, Kazuto Okuzaki, Yuya Gee, Peter Kunihiro, Yayoi Sonpho, Ekasit Xu, Huaigeng Sasakawa, Noriko Naito, Yuki Nakada, Shinichiro Yamamoto, Takashi Sano, Shigetoshi Hotta, Akitsu Takeda, Junji Mashimo, Tomoji Nat Commun Article Although single-component Class 2 CRISPR systems, such as type II Cas9 or type V Cas12a (Cpf1), are widely used for genome editing in eukaryotic cells, the application of multi-component Class 1 CRISPR has been less developed. Here we demonstrate that type I-E CRISPR mediates distinct DNA cleavage activity in human cells. Notably, Cas3, which possesses helicase and nuclease activity, predominantly triggered several thousand base pair deletions upstream of the 5′-ARG protospacer adjacent motif (PAM), without prominent off-target activity. This Cas3-mediated directional and broad DNA degradation can be used to introduce functional gene knockouts and knock-ins. As an example of potential therapeutic applications, we show Cas3-mediated exon-skipping of the Duchenne muscular dystrophy (DMD) gene in patient-induced pluripotent stem cells (iPSCs). These findings broaden our understanding of the Class 1 CRISPR system, which may serve as a unique genome editing tool in eukaryotic cells distinct from the Class 2 CRISPR system. Nature Publishing Group UK 2019-12-06 /pmc/articles/PMC6897959/ /pubmed/31811138 http://dx.doi.org/10.1038/s41467-019-13226-x Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Morisaka, Hiroyuki
Yoshimi, Kazuto
Okuzaki, Yuya
Gee, Peter
Kunihiro, Yayoi
Sonpho, Ekasit
Xu, Huaigeng
Sasakawa, Noriko
Naito, Yuki
Nakada, Shinichiro
Yamamoto, Takashi
Sano, Shigetoshi
Hotta, Akitsu
Takeda, Junji
Mashimo, Tomoji
CRISPR-Cas3 induces broad and unidirectional genome editing in human cells
title CRISPR-Cas3 induces broad and unidirectional genome editing in human cells
title_full CRISPR-Cas3 induces broad and unidirectional genome editing in human cells
title_fullStr CRISPR-Cas3 induces broad and unidirectional genome editing in human cells
title_full_unstemmed CRISPR-Cas3 induces broad and unidirectional genome editing in human cells
title_short CRISPR-Cas3 induces broad and unidirectional genome editing in human cells
title_sort crispr-cas3 induces broad and unidirectional genome editing in human cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6897959/
https://www.ncbi.nlm.nih.gov/pubmed/31811138
http://dx.doi.org/10.1038/s41467-019-13226-x
work_keys_str_mv AT morisakahiroyuki crisprcas3inducesbroadandunidirectionalgenomeeditinginhumancells
AT yoshimikazuto crisprcas3inducesbroadandunidirectionalgenomeeditinginhumancells
AT okuzakiyuya crisprcas3inducesbroadandunidirectionalgenomeeditinginhumancells
AT geepeter crisprcas3inducesbroadandunidirectionalgenomeeditinginhumancells
AT kunihiroyayoi crisprcas3inducesbroadandunidirectionalgenomeeditinginhumancells
AT sonphoekasit crisprcas3inducesbroadandunidirectionalgenomeeditinginhumancells
AT xuhuaigeng crisprcas3inducesbroadandunidirectionalgenomeeditinginhumancells
AT sasakawanoriko crisprcas3inducesbroadandunidirectionalgenomeeditinginhumancells
AT naitoyuki crisprcas3inducesbroadandunidirectionalgenomeeditinginhumancells
AT nakadashinichiro crisprcas3inducesbroadandunidirectionalgenomeeditinginhumancells
AT yamamototakashi crisprcas3inducesbroadandunidirectionalgenomeeditinginhumancells
AT sanoshigetoshi crisprcas3inducesbroadandunidirectionalgenomeeditinginhumancells
AT hottaakitsu crisprcas3inducesbroadandunidirectionalgenomeeditinginhumancells
AT takedajunji crisprcas3inducesbroadandunidirectionalgenomeeditinginhumancells
AT mashimotomoji crisprcas3inducesbroadandunidirectionalgenomeeditinginhumancells